SCHEMBL21701977

SCHEMBL21701977

N#Cc1cccc2c1-c1c(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cccc1C21c2ccccc2Sc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.36
ESR2 Q92731 1/20 0.33
SSTR2 P30874 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MGLL Q99685 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
ADORA2A P29274 2/20 0.31
ADORA1 P30542 2/20 0.31
ALOX15 P16050 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
TSHR P16473 1/20 0.31
ADORA2B P29275 1/20 0.31
GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701915 0.94 MEN1 (0.36) PDK2NPSR1GABRG2GABRB3GABRA5
SCHEMBL21702199 0.90 ABCG2 (0.39) PDK2CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL23257108 0.87 PDK2 (0.33) PDK2ESR2
SCHEMBL23256857 0.87 PDK2 (0.38) PDK2ESR2SSTR2
SCHEMBL21701888 0.87 ABCG2 (0.37) PDK2GABRG2GABRB3GABRA5GABRA3
SCHEMBL21702210 0.86 ABCG2 (0.39) PDK2CYP1A2CYP2C9CYP2C19ADORA2A
SCHEMBL23257129 0.86 PDK2 (0.36) PDK2GABRG2GABRB3GABRA5GABRA3
SCHEMBL21701893 0.85 ADORA3 (0.30) ADORA2AADORA1ALOX15ADORA3TSHR
SCHEMBL21701898 0.85 MEN1 (0.34) PDK2CYP1A2CYP2C9CYP2C19ADORA2A
SCHEMBL21151247 0.84 ADORA3 (0.35) PDK2ADORA2AADORA1ALOX15ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 PDK2 1415/4885ESR2 461/4885SSTR2 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.